Diversity of DNA-hydrolyzing antibodies from the sera of autoimmune-prone MRL/MpJ-lpr mice

Journal of Molecular Recognition

Volumn 24, Issue 4, 2011, Pages 557-569

  Kostrikina, Irina A ^a   Kolesova, Marina E ^a   Orlovskaya, Irina A ^b   Buneva, Valentina N ^a   Nevinsky, Georgy A ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

Author keywords

abzymes of MRL MpJ lpr mice; DNA hydrolysis

Indexed keywords

BOVINAE; MUS;

EID: 79953772947     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.1067     Document Type: Article

References (59)

1. Andrievskaya OA, Buneva VN, Naumov VA, Nevinsky GA,. 2000. Catalytic heterogeneity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus. Med. Sci. Monit. 6: 460-470. (Pubitemid 30432128)
2. Andrievskaya OA, Buneva VN, Baranovskii AG, Gal'vita AV, Benzo ES, Naumov VA, Nevinsky GA,. 2002. Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus. Immunol. Lett. 81: 191-198. (Pubitemid 34310224)
3. Andryushkova AA, Kuznetsova IA, Orlovskaya IA, Buneva VN, Nevinsky GA,. 2006. Antibodies with amylase activity from the sera of autoimmune-prone MRL/MpJ-lpr mice. FEBS Lett. 580: 5089-5095. (Pubitemid 44332384)
4. Andryushkova AA, Kuznetsova IA, Buneva VN, Toporkova LB, Sakhno LV, Tichonova MA, Chernykh ER, Orlovskaya IA, Nevinsky GA,. 2007. Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoetic progenitors. J. Cell. Mol. Med. 11: 531-551. (Pubitemid 47153462)
5. Avalle B, Friboulet A, Thomas D,. 1998. Screening of inhibitory monoclonal antibodies. A critical step for producing anti-idiotypic catalytic antibodies. Ann. N.Y. Acad. Sci. 864: 118-130. (Pubitemid 29048102)
6. Baranovskii AG, Matushin VG, Vlassov AV, Zabara VG, Naumov VA, Giege R, Buneva VN, Nevinsky GA,. 1997. DNA- and RNA-hydrolyzing antibodies from the blood of patients with various forms of viral hepatitis. Biochemistry Mosc. 62: 1358-1366. (Pubitemid 127595488)
7. Baranovskii AG, Kanyshkova TG, Mogelnitskii AS, Naumov VA, Buneva VN, Gusev EI, Boiko AN, Zargarova TA, Favorova OO, Nevinsky GA,. 1998. Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyse DNA and RNA. Biochemistry Mosc. 63: 1239-1248. (Pubitemid 128585494)
8. Baranovskii AG, Ershova NA, Buneva VN, Kanyshkova TG, Mogelnitskii AS, Doronin BM, Boiko AN, Gusev EI, Favorova OO, Nevinsky GA,. 2001. Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol. Lett. 76: 163-167. (Pubitemid 32295936)
9. Baranovskii AG, Buneva VN, Nevinsky GA,. 2004. Human deoxyribonucleases. Biochemistry Mosc. 69: 587-601.
10. Bernardi G,. 1971. Hydrolysis: Other CN Bonds, Phosphate Esters, Boyer PD, (ed.). Academic Press: New York; 271-287.
11. Bronshtein IB, Shuster AM, Gololobov GV, Gromova II, Kvashuk OA, Belostotskaya KM, Alekberova ZS, Prokaeva TB, Gabibov AG,. 1992. DNA-specific anti-idiotypic antibodies in the sera of patients with autoimmune diseases. FEBS Lett. 314: 259-263. (Pubitemid 23005668)
12. Buneva VN, Andrievskaya OA, Romannikova IV, Gololobov GV, Yadav RP, Yamkovoi VI, Nevinskii GA,. 1994. Interaction of catalytically active antibodies with oligoribonucleotides. Mol. Biol. (Mosk.) 28: 738-743.
13. Catalytic Antibodies. 2005., Keinan EE, (ed.). Wiley-VCH Verlag GmbH and Co. KgaA: Germany; 1-586.
14. Cornish-Bowden A,. 1976. Principles of Enzyme Kinetics. Butterworths: London.
15. Debat H, Avalle B, Chose O, Sarde CO, Friboulet A, Thomas D,. 2001. Overpassing an aberrant V(kappa) gene to sequence an anti-idiotypic abzyme with (beta)-lactamase-like activity that could have a linkage with autoimmune diseases. FASEB J. 15: 815-822. (Pubitemid 32246000)
16. Dubrovskaya VV, Andryushkova AS, Kuznetsova IA, Toporkova LB, Buneva VN, Orlovskaya IA, Nevinsky GA,. 2003. DNA-hydrolyzing antibodies from sera of autoimmune-prone MRL/MpJ-lpr mice. Biochemistry Mosc. 68: 1081-1088.
17. Founel S, Muller S,. 2002. Antinucleosome antibodies and T-cell response in systemic lupus erythematosus. Ann. Med. Interne (Paris) 153: 513-519. (Pubitemid 36133227)
18. Friboulet A, Izadyar L, Avalle B, Roseto A, Thomas D,. 1994. Abzyme generation using an anti-idiotypic antibody as the "internal image" of an enzyme active site. Appl. Biochem. Biotechnol. 47: 229-237.
19. Gololobov GV, Mikhalap SV, Starov AV, Kolesnikov AF, Gabibov AG,. 1994. Natural targets for DNA-hydrolyzing antibodies. Appl. Biochem. Biotechnol. 47: 305-314.
20. Gololobov GV, Chernova EA, Schourov DV, Smirnov IV, Kudelina IA, Gabibov AG,. 1995. Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique. Proc. Natl. Acad. Sci. U.S.A. 92: 254-257.
21. Hifumi E, Morihara F, Hatiuchi K, Okuda T, Nishizono A, Uda T,. 2008. Catalytic features and eradication ability of antibody light-chain UA15-L against Helicobacter pylori. J. Biol. Chem. 283: 899-907.
22. Hu R, Xie GY, Zhang X, Guo ZQ, Jin S,. 1998. Production and characterization of monoclonal anti-idiotypic antibody exhibiting a catalytic activity similar to carboxypeptidase A. J. Biotechnol. 61: 109-115. (Pubitemid 28269320)
23. Ikhmyangan EN, Vasilenko NL, Buneva VN, Nevinsky GA,. 2006. Metal ions-dependent peroxidase and oxidoreductase activities of polyclonal IgGs from the sera of Wistar rats. J. Mol. Recognit. 19: 91-105. (Pubitemid 43374166)
24. Izadyar L, Friboulet A, Remy MH, Roseto A, Thomas D,. 1993. Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity. Proc. Natl. Acad. Sci. U.S.A. 90: 8876-8880. (Pubitemid 23306413)
25. Kalaga R, Li L, O'Dell JR, Paul S,. 1995. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J. Immunol. 155: 2695-2702.
26. Kolesnikov AV, Kozyr AV, Alexandrova ES, Koralewski F, Demin AV, Titov MI, Avalle B, Tramontano A, Paul S, Thomas D, Gabibov AG, Friboulet A,. 2000. Enzyme mimicry by the anti-idiotypic antibody approach. Proc. Natl. Acad. Sci. U.S.A. 97: 13526-13531.
27. Kozyr AV, Kolesnikov A, Aleksandrova ES, Sashchenko LP, Gnuchev N, Favorov PV, Kotelnikov MA, Iakhnina EI, Astsaturov IA, Prokaeva TB, Alekberova ZS, Suchkov SV, Gabibov AG,. 1998. Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl. Biochem. Biotechnol. 75: 45-61. (Pubitemid 29168618)
28. Krasnorutskii MA, Buneva VN, Nevinsky GA,. 2008a. Antibodies against DNA hydrolyze DNA and RNA. Biochemistry Mosc. 73: 1547-1560.
29. Krasnorutskii MA, Buneva VN, Nevinsky GA,. 2008b. Antibodies against RNA hydrolyze RNA and DNA. J. Mol. Recognit. 21: 337-346.
30. Krasnorutskii MA, Buneva VN, Nevinsky GA,. 2008c. Immunization of rabbits with DNase I produces polyclonal antibodies with DNase and RNase activities. J. Mol. Recognit. 21: 233-242. (Pubitemid 352019053)
31. Krasnorutskii MA, Buneva VN, Nevinsky GA,. 2008d. Anti-RNase Antibodies against pancreatic ribonuclease A hydrolyze RNA and DNA. Int. Immunol. 20: 1031-1040.
32. Krasnorutskii MA, Buneva VN, Nevinsky GA,. 2009. Immunization of rabbits with DNase II leads to formation of polyclonal antibodies with DNase and RNase activities. Int. Immunol. 21: 349-360.
33. Kubota T,. 1977. Lessons from a monoclonal antibody to double-stranded DNA. J. Med. Dent. Sci. 44: 37-44.
34. Kuznetsova IA, Orlovskaya IA, Buneva VN, Nevinsky GA,. 2007. Activation of DNA-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice by different metal ions. Biochim. Biophys. Acta 1774: 884-896. (Pubitemid 46977842)
35. Mitsuhashi S, Saito R, Kurashige S, Yamashugi N,. 1978. Ribonucleic acid in the immune response. Moll. Cell. Biochem. 20: 131-147. (Pubitemid 9006498)
36. Nagata S, Suda T,. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16: 39-43.
37. Nevinsky GA, Kanyshkova TG, Buneva VN,. 2000a. Natural catalytic antibodies (abzymes) in normalcy and pathology. Biochemistry Mosc. 65: 1245-1255.
38. Nevinsky GA, Kanyshkova TG, Semenov DV, Vlassov AV, Gal'vita AV, Buneva VN,. 2000b. Secretory immunoglobulin A from healthy human mothers' milk catalyzes nucleic acid hydrolysis. Appl. Biochem. Biotechnol. 83: 115-129.
39. Nevinsky GA, Favorova OO, Buneva VN,. 2002a. Catalytic antibodies: New characters in the protein repertoire. In Protein-Protein Interactions. A Molecular Cloning Manual. Cold Spring Harbor: NY; 523-534.
40. Nevinsky GA, Buneva VN,. 2002b. Human catalytic RNA- and DNA-hydrolyzing antibodies. J. Immunol. Methods 269: 235-249.
41. Nevinsky GA, Buneva VN,. 2003. Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies. J. Cell. Mol. Med. 7: 265-276. (Pubitemid 37372046)
42. Nevinsky GA, Buneva VN,. 2005. Natural catalytic antibodies-abzymes. In Catalytic Antibodies, Keinan E, (ed.). Wiley-VCH Verlag GmbH and Co. KgaA: Germany; 503-567.
43. Nishi Y,. 2002. Evolution of catalytic antibody repertoire in autoimmune mice. J. Immunol. Methods 269: 213-233.
44. Odintsova ES, Buneva VN, Nevinsky GA,. 2005. Casein-hydrolyzing activity of sIgA antibodies from human milk. J. Mol. Recognit. 18: 413-421. (Pubitemid 41336795)
45. Odintsova ES, Kharitonova MA, Baranovskii AG, Siziakina LP, Buneva VN, Nevinsky GA,. 2006. DNA-hydrolyzing IgG antibodies from the blood of patients with acquired immune deficiency syndrome. Mol. Biol. (Mosk.) 40: 857-864.
46. Odintsova ES, Zaksas NP, Buneva VN, Nevinsky GA,. 2010. Metal dependent hydrolysis of beta-casein by sIgA antibodies from human milk. J. Mol. Recognit. DOI: 10.1002/jmr.1022 [Epub ahead of print].
47. Paul S, Volle DJ, Beach CM, Johnson DR, Powell MJ, Massey RJ,. 1989. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 244: 1158-1162. (Pubitemid 19170484)
48. Polosukhina DI, Kanyshkova TG, Doronin BM, Tyshkevich OB, Buneva VN, Boiko AN, Gusev EI, Favorova OO, Nevinsky GA,. 2004. Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis. J. Cell Mol. Med. 8: 359-368. (Pubitemid 44145499)
49. Polosukhina DI, Kanyshkova TG, Doronin BM, Tyshkevich OB, Buneva VN, Boiko AN, Gusev EI, Nevinsky GA, Favorova OO,. 2006. Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. Immunol. Lett. 103: 75-81. (Pubitemid 43162949)
50. Savel'ev AN, Kanyshkova TG, Kulminskaya AA, Buneva VN, Eneyskaya EV, Filatov MV, Nevinsky GA, Neustroev KN,. 2001. Amylolytic activity of IgG and sIgA immunoglobulins from human milk. Clin. Chim. Acta 314: 141-152. (Pubitemid 33079192)
51. Semenov DV, Kanyshkova TG, Karotaeva NA, Krasnorutskii MA, Kuznetsova IA, Buneva VN, Nevinsky GA,. 2004. Catalytic nucleotide-hydrolyzing antibodies in milk and serum of clinically healthy human mothers. Med. Sci. Monit. 10: BR23-BR33. (Pubitemid 38233056)
52. Shuster AM, Gololobov GV, Kvashuk OA, Bogomolova AE, Smirnov IV, Gabibov AG,. 1992. DNA hydrolyzing autoantibodies. Science 256: 665-667.
53. Sinohara H, Matsuura K,. 2000. Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma? Appl. Biochem. Biotechnol. 83: 85-94.
54. Suck D,. 1994. DNA recognition by DNase I. J. Mol. Recognit. 7: 65-70. (Pubitemid 2125870)
55. Tawfik DS, Chap R, Green BS, Sela M, Eshhar Z,. 2002. Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity? Proc. Natl. Acad. Sci. U.S.A. 92: 2145-2149.
56. Tolmacheva AS, Zaksas NP, Buneva VN, Vasilenko NL, Nevinsky GA,. 2009. Oxidoreductase activities of polyclonal IgGs from the sera of Wistar rats are better activated by combinations of different metal ions. J. Mol. Recognit. 22: 26-37.
57. Vlassov A, Florentz C, Helm M, Naumov V, Buneva V, Nevinsky G, Giege R,. 1998a. Characterization and selectivity of catalytic antibodies from human serum with RNase activity. Nucleic Acids Res. 26: 5243-5250. (Pubitemid 28542720)
58. Vlassov AV, Baranovskii AG, Kanyshkova TG, Prints AV, Zabara VG, Naumov VA, Breusov AA, Giege R, Buneva VN, Nevinsky GA,. 1998b. Substrate specificity of DNA- and RNA-hydrolyzing antibodies from blood of patients with polyarthritis and Hashimoto's thyroiditis. Mol. Biol. (Mosk.) 32: 559-569. (Pubitemid 128742610)
59. Watanabe-Fukunada R, Brannan CI, Copeland NG,. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.